Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandbehandling i udlandet ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.2% 1.2%   Bankruptcy risk   4.6% 6.6% 15.6% 13.4% 13.2% 39.3% 16.1% 16.0%   Credit score (0-100)   47 37 12 16 16 0 11 12   Credit rating   BBB BBB BB BB BB C BB BB   Credit limit (kDKK)   0.0 0.0 0.0 -0.0 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 921 0 0 0 0 0   Gross profit   1,940 1,376 340 61.2 406 24.6 0.0 0.0   EBITDA   468 114 -531 -614 -43.7 -752 0.0 0.0   EBIT   468 114 -531 -614 -43.7 -752 0.0 0.0   Pre-tax profit (PTP)   457.8 102.7 -533.3 -621.3 -56.4 -761.0 0.0 0.0   Net earnings   356.2 79.1 -509.5 -621.3 -56.4 -611.9 0.0 0.0   Pre-tax profit without non-rec. items   458 103 -536 -621 -56.4 -761 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   1,039 1,118 608 -28.4 -84.7 -697 -822 -822   Interest-bearing liabilities   114 464 46.0 192 156 28.3 822 822   Balance sheet total (assets)   1,541 1,815 956 411 353 884 0.0 0.0   Net Debt   -137 121 31.0 -88.0 91.3 27.8 822 822     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 921 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,940 1,376 340 61.2 406 24.6 0.0 0.0   Gross profit growth   8.4% -29.1% -75.3% -82.0% 562.3% -93.9% -100.0% 0.0%   Employees   3 3 0 0 2 2 0 0   Employee growth %   -25.0% 0.0% -100.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,541 1,815 956 411 353 884 0 0   Balance sheet change%   -18.3% 17.8% -47.3% -57.0% -14.2% 150.8% -100.0% 0.0%   Added value   468.4 113.8 -531.2 -614.3 -43.7 -752.3 0.0 0.0   Added value %   0.0% 0.0% -57.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 -1.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% -57.7% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% -57.7% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   24.1% 8.3% -156.2% -1,003.3% -10.8% -3,060.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% -55.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% -55.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% -58.2% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   27.3% 6.8% -38.3% -88.0% -10.0% -74.5% 0.0% 0.0%   ROI %   34.5% 8.3% -44.8% -125.2% -25.0% -814.5% 0.0% 0.0%   ROE %   41.4% 7.3% -59.1% -121.9% -14.8% -98.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   67.4% 61.6% 63.6% -6.5% -19.4% -44.1% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 37.8% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 36.1% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -29.3% 106.7% -5.8% 14.3% -209.1% -3.7% 0.0% 0.0%   Gearing %   11.0% 41.5% 7.6% -678.1% -184.6% -4.1% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.1% 3.9% 2.0% 5.9% 7.3% 9.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.1 2.8 4.5 0.9 0.8 0.6 0.0 0.0   Current Ratio   3.1 2.8 4.5 0.9 0.8 0.6 0.0 0.0   Cash and cash equivalent   251.2 342.8 15.1 280.3 65.1 0.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 320.1 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 103.8% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,038.6 1,161.2 742.8 -28.4 -84.7 -696.6 -410.8 -410.8   Net working capital %   0.0% 0.0% 80.7% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   156 38 0 0 -22 -376 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   156 38 0 0 -22 -376 0 0   EBIT / employee   156 38 0 0 -22 -376 0 0   Net earnings / employee   119 26 0 0 -28 -306 0 0